- Home
- About
- About NephU
- Meet The Team
- Supporting Organizations
- Community Advisors
- Contact Us
- Diversity, Equity, & Inclusion
- IgAN
- Events
- Resource Center
- Rare Kidney Diseases (PKD, IgAN, & Others)
- Kidney Disease & Mental Health
- Kidney Disease & Comorbid Conditions
- Transplantation & Dialysis
- NephU Nutrition & The NephChefR
- Radiology Toolkit
- On Demand Webinars
- Infographics
- Podcasts
- Videos
- Request a Presentation
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
Archives
Major Depressive Disorder In Chronic Kidney Disease – Limited Access
The burden of Chronic Kidney Disease (CKD) for patients is multifactorial, including having psychiatric consequences such as Major Depressive Disorder (MDD). While the interplay between the two is not clearly defined, both CKD and MDD can impact medical outcomes. In this discussion, Dr. Green and Dr. Meyer will discuss the challenges and opportunities for patients with these comorbid conditions.
Speakers are employees for Otsuka Pharmaceutical Development & Commercialization, Inc.
This event is Private.Featured Speakers
Jill A Green, PhD
Nephrology Medical Science DirectorOtsuka Pharmaceutical Development & Commercialization, Inc.*
Jill A Green, PhD, is a Medical Science Director in the nephrology division at Otsuka Pharmaceutical Development & Commercialization, Inc. Dr Green received her PhD in biomedical sciences, with a specialization in biochemical and molecular basis of disease. She went on to hold a research scientist role at The James Comprehensive Cancer Center at The Ohio State University, specializing in oncology pre-clinical research before taking a position as a Regulatory Compliance Officer where she managed thoracic oncology clinical trials at The James Cancer Hospital.
Dr Green has been a proud member of the PKD Foundation – Columbus, Ohio chapter for over 12 years where she has been active in fundraising and advocacy efforts.
Chip Meyer, PhD
Senior Medical Science Liaison-
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Chip Meyer, PhD, is a Senior Medical Science Liaison in the neuroscience division at Otsuka Pharmaceutical Development & Commercialization, Inc. Dr. Meyer received hisPhD in Behavioral Neuroscience and Psychopharmacology from the University of Kentucky where he conducted pre-clinical research and drug development in the area of substance use disorders. He went on to complete a postdoctoral fellowship in Human BehavioralPharmacology at the University of Vermont where he conducted clinical research in substance use disorders.
Event Navigation
Join Today for Instant Access to all NephU Offerings.
Membership is free!
Join NephU today at no cost to register for this event and access to other premium content.
- The NephU Community is collaborating to improve care and the future outcomes for individuals with kidney disease and other related conditions.
- Quickly learn more about the topics that interest you.
- Access our library of on-demand kidney health resources
- Gain key insights from industry experts & though leaders.
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2024 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved.